Pushkal Garg, EVP Chief R&D: Alnylam Pharmaceuticals ALNY Sell · Filed 03/06

Trade details

Type: Insider sale
Amount: $210,803.82
Shares · price: 654 sh · $322.33 a share
Held after: 20,443 sh
Stock: Alnylam Pharmaceuticals ALNY
Person: Pushkal GargEVP Chief R&D
Trade date: 26/03/05
Filed: 26/03/06
Days to filing: 1 days

Sold 3.1% of holdings

Share of holding sold: 3.1%

Alnylam Pharmaceuticals trades, last 26 weeks

What else happened in Alnylam Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 02/03~04/04

Pushkal Garg's recent trades

Pushkal GargEVP Chief R&D
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$248.4K
767 sh
$248.4K
Filed 03/06
Traded 03/04
Pushkal GargEVP Chief R&D
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$239.4K
740 sh
$239.4K
Filed 03/06
Traded 03/05
Pushkal GargEVP Chief R&D
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$165.5K
510 sh
$165.5K
Filed 03/06
Traded 03/05
Pushkal GargEVP Chief R&D
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$163K
500 sh
$163K
Filed 03/06
Traded 03/05
Pushkal GargEVP Chief R&D
Sell10b5-1 planAlnylam Pharmaceuticals
Sell10b5-1 plan
Alnylam Pharmaceuticals
ALNY
$113.1K
350 sh
$113.1K
Filed 03/06
Traded 03/04

Pushkal Garg, Chief Officer — sold $210.8K of Alnylam Pharmaceuticals ALNY · 3.1% of holdings · 10b5-1 plan | Whalegun